Antibiotic resistance is a growing crisis in which existing antibiotics lose effectiveness against certain pathogens
Antimicrobial peptides (AMPs) are a rich source of novel antibiotics with the potential to target antibiotic-resistant bacteria
Synthesizing proteins (such as AMPs) using recombinant gene expression is a fast, convenient, and inexpensive method
Expressing AMPs in bacteria, however, is challenging given they target the very bacteria that's producing them
Our project aims to solve this issue by sequestering the AMPs within encapsulin nanocompartments as they are produced